Genetic association of neurotrophic tyrosine kinase receptor type 2 (NTRK2) with Alzheimer's disease

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 147, Issue 3, 2008, Pages 363-369

  Chen, Zuomin ^a   Simmons, Micah S ^a   Perry, Rodney T ^a   Wiener, Howard W ^a   Harrell, Lindy E ^b,c   Go, Rodney C P ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ALABAMA HOSPITAL   (United States)

Author keywords

Haplotype; Linkage; SNP; Splicing; TRKB

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; NERVE GROWTH FACTOR; NEUROTROPHIN; NEUROTROPHIN 3; PROTEIN TYROSINE KINASE A; TYROSINE RECEPTOR KINASE C; UNCLASSIFIED DRUG;

ADULT; AGED; ALTERNATIVE RNA SPLICING; ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; FEMALE; GENE CONTROL; GENE LOCATION; GENE LOCUS; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC CODE; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; LONG TERM POTENTIATION; MAJOR CLINICAL STUDY; MALE; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ALTERNATIVE SPLICING; ALZHEIMER DISEASE; BASE SEQUENCE; DNA PRIMERS; GENOTYPE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, TRKB;

EID: 42149106225     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30607     Document Type: Article

References (51)

1. Akey J, Jin L, Xiong M. 2001. Haplotypes vs single marker linkage disequilibrium tests: What do we gain? Eur J Hum Genet 9(4):291-300.
2. Allen SJ, Wilcock GK, Dawbarn D. 1999. Profound and selective loss of catalytic TrkB immunoreactivity in Alzheimer's disease. Biochem Biophys Res Commun 264(3):648-651.
3. Allendoerfer KL, Cabelli RJ, Escandon E, Kaplan DR, Nikolics K, Shatz CJ. 1994. Regulation of neurotrophin receptors during the maturation of the mammalian visual system. J Neurosci 14(3 Pt 2):1795-1798.
4. Bertram L, Hiltunen M, Parkinson M, Ingelsson M, Lange C, Ramasamy K, Mullin K, Menon R, Sampson AJ, Hsiao MY, et al. 2005. Family-based association between Alzheimer's disease and variants in UBQLN1. N Engl J Med 352(9):884-894.
5. Blacker D, Bertram L, Saunders AJ, Moscarillo TJ, Albert MS, Wiener H, Perry RT, Collins JS, Harrell LE, Go RC, et al. 2003. Results of a high-resolution genome screen of 437 Alzheimer's disease families. Hum Mol Genet 12(1):23-32.
6. Connor B, Young D, Lawlor P, Gai W, Waldvogel H, Faull RL, Dragunow M. 1996. Trk receptor alterations in Alzheimer's disease. Brain Res Mol Brain Res 42(1):1-17.
7. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA. 1993. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261(5123):921-923.
8. Dawbarn D, Allen SJ. 2003. Neurotrophins and neurodegeneration. Neuropathol Appl Neurobiol 29(3):211-230.
9. Dickson MR, Perry RT, Wiener H, Go RC. 2005. Association studies of transforming growth factor-beta 1 and Alzheimer's disease. Am J Med Genet Part B 139B(1):38-41.
10. Dorsey SG, Renn CL, Carim-Todd L, Barrick CA, Bambrick L, Krueger BK, Ward CW, Tessarollo L. 2006. In vivo restoration of physiological levels of truncated TrkB. T1 receptor rescues neuronal cell death in a trisomic mouse model. Neuron 51(1):21-28.
11. Elliott E, Atlas R, Lange A, Ginzburg I. 2005. Brain-derived neurotrophic factor induces a rapid dephosphorylation of tau protein through a PI-3 Kinase signalling mechanism. Eur J Neurosci 22(5):1081-1089.
12. Escandon E, Soppet D, Rosenthal A, Mendoza-Ramirez JL, Szonyi E, Burton LE, Henderson CE, Parada LF, Nikolics K. 1994. Regulation of neurotrophin receptor expression during embryonic and postnatal development. J Neurosci 14(4):2054-2068.
13. Ferrer I, Marin C, Rey MJ, Ribalta T, Goutan E, Blanco R, Tolosa E, Marti E. 1999. BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies. J Neuropathol Exp Neurol 58(7):729-739.
14. Flanagin BA, Cook EH Jr, de Wit H. 2006. An association study of the brain-derived neurotrophic factor Val66Met polymorphism and amphetamine response. Am J Med Genet Part B 141B(6):576-583.
15. Ginsberg SD, Che S, Wuu J, Counts SE, Mufson EJ. 2006. Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease. J Neurochem 97(2):475-487.
16. Glenner GG, Wong CW. 1984. Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun 122(3):1131-1135.
17. Go RC, Perry RT, Wiener H, Bassett SS, Blacker D, Devlin B, Sweet RA. 2005. Neuregulin-1 polymorphism in late onset Alzheimer's disease families with psychoses. Am J Med Genet Part B 139B(1):28-32.
18. Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L, et al. 1991. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349(6311):704-706.
19. Goedert M, Wischik CM, Crowther RA, Walker JE, Klug A. 1988. Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: Identification as the microtubule-associated protein tau. Proc Natl Acad Sci USA 85(11):4051-4055.
20. Horvath S, Xu X, Lake SL, Silverman EK, Weiss ST, Laird NM. 2004. Family-based tests for associating haplotypes with general phenotype data: Application to asthma genetics. Genet Epidemiol 26(1):61-69.
21. Kamboh MI. 2004. Molecular genetics of late-onset Alzheimer's disease. Ann Hum Genet 68(Pt 4):381-404.
22. Laird NM, Horvath S, Xu X. 2000. Implementing a unified approach to family-based tests of association. Genet Epidemiol 19(Suppl 1):S36-S42.
23. Lake SL, Blacker D, Laird NM. 2000. Family-based tests of association in the presence of linkage. Am J Hum Genet 67(6):1515-1525.
24. Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettingell WH, Yu CE, Jondro PD, Schmidt SD, Wang K, et al. 1995. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269(5226):973-977.
25. Li M, Boehnke M, Abecasis GR. 2005a. Joint modeling of linkage and association: Identifying SNPs responsible for a linkage signal. Am J Hum Genet 76(6):934-949.
26. Li Z, Jaboin J, Dennis PA, Thiele CJ. 2005b. Genetic and pharmacologic identification of Akt as a mediator of brain-derived neurotrophic factor/TrkB rescue of neuroblastoma cells from chemotherapy-induced cell death. Cancer Res 65(6):2070-2075.
27. Li Y, Grupe A, Rowland C, Nowotny P, Kauwe JS, Smemo S, Hinrichs A, Tacey K, Toombs TA, Kwok S, et al. 2006. DAPK1 variants are associated with Alzheimer's disease and allele-specific expression. Hum Mol Genet 15(17):2560-2568.
28. Martin-Zanca D, Hughes SH, Barbacid M. 1986. A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences. Nature 319(6056):743-748.
29. McAllister AK, Stevens CF. 2000. Nonsaturation of AMPA and NMDA receptors at hippocampal synapses. Proc Natl Acad Sci USA 97(11):6173-6178.
30. Minichiello L, Korte M, Wolfer D, Kuhn R, Unsicker K, Cestari V, Rossi-Arnaud C, Lipp HP, Bonhoeffer T, Klein R. 1999. Essential role for TrkB receptors in hippocampus-mediated learning. Neuron 24(2):401-414.
31. Murray KD, Gall CM, Jones EG, Isackson PJ. 1994. Differential regulation of brain-derived neurotrophic factor and type II calcium/calmodulin-dependent protein kinase messenger RNA expression in Alzheimer's disease. Neuroscience 60(1):37-48.
32. Nagappan G, Lu B. 2005. Activity-dependent modulation of the BDNF receptor TrkB: Mechanisms and implications. Trends Neurosci 28(9):464-471.
33. Nakagawara A, Liu XG, Ikegaki N, White PS, Yamashiro DJ, Nycum LM, Biegel JA, Brodeur GM. 1995. Cloning and chromosomal localization of the human TRK-B tyrosine kinase receptor gene (NTRK2). Genomics 25(2):538-546.
34. Perry RT, Collins JS, Harrell LE, Acton RT, Go RC. 2001. Investigation of association of 13 polymorphisms in eight genes in southeastern African American Alzheimer disease patients as compared to age-matched controls. Am J Med Genet 105(4):332-342.
35. Perry RT, Wiener H, Harrell LE, Blacker D, Tanzi RE, Bertram L, Bassett SS, Go RC. 2007. Follow-up mapping supports the evidence for linkage in the candidate region at 9q22 in the NIMH Alzheimer's disease Genetics Initiative cohort. Am J Med Genet Part B 144B(2):220-227.
36. Phillips HS, Hains JM, Armanini M, Laramee GR, Johnson SA, Winslow JW. 1991. BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease. Neuron 7(5):695-702.
37. Riva A, Kohane IS. 2001. A web-based tool to retrieve human genome polymorphisms from public databases. Proc AMIA Symp:558-562.
38. Riva A, Kohane IS. 2002. SNPper: Retrieval and analysis of human SNPs. Bioinformatics 18(12):1681-1685.
39. Riva A, Kohane IS. 2004. A SNP-centric database for the investigation of the human genome. BMC Bioinformatics 5:33.
40. Robertson RT, Baratta J, Yu J, Guthrie KM. 2006. A role for neurotrophin-3 in targeting developing cholinergic axon projections to cerebral cortex. Neuroscience 143(2):523-539.
41. Salerno MS, Mordvinov VA, Sanderson CJ. 2000. Binding of octamer factors to a novel 3′-positive regulatory element in the mouse interleukin-5 gene. J Biol Chem 275(6):4525-4531.
42. Sangwan I, O'Brian MR. 2002. Identification of a soybean protein that interacts with GAGA element dinucleotide repeat DNA. Plant Physiol 129(4):1788-1794.
43. SAS Inc. 2004. SAS. Version 9.1. Cary, NC, USA: SAS Institute Inc.
44. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K, et al. 1995. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375(6534):754-760.
45. Snider WD. 1994. Functions of the neurotrophins during nervous system development: What the knockouts are teaching us. Cell 77(5):627-638.
46. Stoilov P, Castren E, Stamm S. 2002. Analysis of the human TrkB gene genomic organization reveals novel TrkB isoforms, unusual gene length, and splicing mechanism. Biochem Biophys Res Commun 290(3):1054-1065.
47. Strohmaier C, Carter BD, Urfer R, Barde YA, Dechant G. 1996. A splice variant of the neurotrophin receptor trkB with increased specificity for brain-derived neurotrophic factor. EMBO J 15(13):3332-3337.
48. Tran Q, Coleman TP, Roesser JR. 2003. Human transformer 2beta and SRp55 interact with a calcitonin-specific splice enhancer. Biochim Biophys Acta 1625(2):141-152.
49. van Duijn CM, de Knijff P, Cruts M, Wehnert A, Havekes LM, Hofman A, Van Broeckhoven C. 1994. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. Nat Genet 7(1):74-78.
50. Vepsalainen S, Castren E, Helisalmi S, Iivonen S, Mannermaa A, Lehtovirta M, Hanninen T, Soininen H, Hiltunen M. 2005. Genetic analysis of BDNF and TrkB gene polymorphisms in Alzheimer's disease. J Neurol 252(4):423-428.
51. Wjst M. 2004. Target SNP selection in complex disease association studies. BMC Bioinformatics 5:92.